Empire Financial Management Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$549K Buy
7,648
+425
+6% +$32.7K 0.12% 149
2025
Q4
$573K Buy
7,223
+25
+0.3% +$1.97K 0.12% 145
2025
Q3
$543K Hold
7,198
0.12% 148
2025
Q2
$497K Buy
7,198
+1,957
+37% +$128K 0.14% 145
2025
Q1
$355K Hold
5,241
0.11% 164
2024
Q4
$235K Buy
5,241
+475
+10% +$26.6K 0.07% 184
2024
Q3
$300K Sell
4,766
-510
-10% -$29.8K 0.09% 175
2024
Q2
$312K Sell
5,276
-2,533
-32% -$158K 0.1% 168
2024
Q1
$623K Buy
7,809
+125
+2% +$9.55K 0.21% 126
2023
Q4
$607K Sell
7,684
-6,978
-48% -$497K 0.24% 109
2023
Q3
$1.02M Sell
14,662
-21,181
-59% -$1.5M 0.45% 65
2023
Q2
$2.48M Buy
35,843
+2,545
+8% +$181K 0.99% 31
2023
Q1
$2.47M Buy
+33,298
New +$2.79M 1.01% 32

Other funds holding CVS

Empire Financial Management Company's CVS Position: Q1 2026 in Review

Empire Financial Management Company increased its CVS Health (CVS) stake by 5.9% in Q1 2026, buying an estimated $32.7K and bringing the position to 7,648 shares worth $549K. The position accounts for 0.12% of the portfolio, ranked #149.

Empire Financial Management Company first reported a position in CVS in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.48M in Q2 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Empire Financial Management Company held 7,648 shares of CVS Health worth $549K as of Q1 2026.
  • Empire Financial Management Company bought 425 CVS Health shares in Q1 2026, an estimated $32.7K.
  • CVS Health made up 0.12% of Empire Financial Management Company's portfolio in Q1 2026, its #149 holding.
  • Empire Financial Management Company first reported a position in CVS Health in Q1 2023 and has held it in 13 quarters since.
  • Empire Financial Management Company's CVS Health position peaked at $2.48M in Q2 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.